Latest Regulatory Approval News

Galilee Energy has confirmed the final location for its Zydeco-1 well in Louisiana, targeting significant gas and condensate resources with drilling set for the second quarter of 2026. The well also aims to explore additional oil potential, optimising costs and environmental impact.

Prodigy Gold has updated its Hyperion Gold deposit resource, boosting indicated ounces by 70% to 212,000 ounces and increasing the total resource to 454,000 ounces. This reflects successful 2025 drilling and improved confidence ahead of a planned scoping study.

Australian Strategic Materials and Energy Fuels have amended their acquisition deal, replacing a special dividend with a direct cash payment to ASM shareholders, while maintaining the original share swap terms.

H3 Energy has appointed LAB Energy Advisors to spearhead farm-in talks for its Alinya project, a vast and underexplored oil and gas prospect in South Australia’s Officer Basin. The move aims to accelerate partner engagement ahead of drilling a potentially game-changing well.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.

Westgold Resources has completed the demerger of its non-core Reedy and Comet Projects to newly formed Valiant Gold, which has attracted $75 million in oversubscribed IPO applications ahead of its ASX debut.

Australian Oil Company Limited has formalised a 12-month crude oil lifting agreement with IOR Energy for its Emu Apple Oil Field, paving the way for steady cash flow and further development in the Surat Basin.

Asian Battery Metals has exercised its option to acquire the Maikhan Uul Copper-Gold Project in southwestern Mongolia, adding a strategically significant asset to its portfolio with confirmed high-grade mineralisation and a long-term mining licence.

Javelin Minerals has secured a major new gold exploration package in Western Australia’s Central Yilgarn region, setting the stage for an aggressive exploration campaign near established projects.

Aguia Resources has secured key mining concessions in Brazil, setting the stage for operational licensing and commissioning of its Tres Estradas phosphate mine by April 2026.

Alchemy Resources has agreed to sell its Karonie and Lake Rebecca gold projects to Forrestania Resources for $5 million in shares, while retaining a 1% royalty. This deal marks a strategic refocus on Alchemy’s promising New South Wales assets.

Patrys has initiated manufacturing and regulatory steps for RLS-2201, its injectable Quetiapine formulation targeting delirium, aiming for Phase 0 trials in the second half of 2026.